Gynecology Drugs Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028

Global Gynecology Drugs Market: Key Segments

The global gynecology drugs market has been segmented based on therapeutics, indication, distribution channel, and region. Furthermore, in terms of therapeutics, the market has been divided into hormonal therapy and non-hormonal therapy. The non-hormonal therapy segment is likely to account for a leading share of the global market during the forecast period owing to the effectiveness of the products, rise in adoption of these products, and new product development. Decreasing use of hormonal products due to the risk of breast cancer has boosted the demand for non-hormonal pharmaceutical products. In terms of indication, the global market has been classified into gynecology cancers, endometriosis, female infertility, menopausal disorder, gynecology infections, polycystic ovary syndrome, contraception (birth control), and others. In terms of distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies. The online pharmacies segment is estimated to expand at a significant CAGR during forecast period, owing to the ease of use of online pharmacies and a rise in the number of internet users. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Gynecology Drugs Market: Regional Outlook

In terms of region, the global gynecology drugs market has been segmented into five major regions and key countries/sub-regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global gynecology drugs market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key players in the global gynecology drugs market are Eli Lilly and Company, Pfizer, Inc., Merck & Co., Inc, Amgen Inc., AstraZeneca, F. Hoffmann-La Roche Ltd., Allergan Plc, and Bayer AG.

The global gynecology drugs market has been segmented as given below:

Global Gynecology Drugs Market, by Therapeutics
Hormonal Therapy
Estrogen Therapy
Progestin Therapy
Combination Therapy
Thyroid Replacement Therapy
Parathyroid Hormone Therapy
Others
Non-hormonal Therapy
Anti-Infective Agents
Anti-neoplastic Agents
Anti-inflammatory Agents
Others
Global Gynecology Drugs Market, by Indication
Gynecology Cancers
Endometriosis
Female Infertility
Menopausal Disorder
Gynecology Infections
Polycystic Ovary Syndrome
Contraception (Birth Control)
Others
Global Gynecology Drugs Market, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Gynecology Drugs Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.